Color Health

At a glance

Pricing

Enterprise contract.

HIPAA

Not disclosed

SOC 2

Not disclosed

EHRs

—

Founded

—

Bottom line

Population genomics + preventive-care analytics for employers.

Free tier available.

Overview

Pricing

What it costs

Free tier only; no paid plans publicly disclosed.

Source: vendor pricing page. Verified May 23, 2026.

Peer-reviewed coverage

What the literature says

1 peer-reviewed study indexed on PubMed evaluate Color Health in clinical contexts. The most relevant are shown below, ranked by editorial relevance score combining title match, study design, recency, and journal tier.

Outcomes from a Novel Approach to Studying Consumer Genetic Testing for Germline Cancer and Cardiovascular Risk.

Kilbride MK, Chavez-Yenter D, Wong B, et al.· Am J Med Genet A· 2025

Despite the growing availability of consumer genetic testing for serious disease risks, outcomes data remain limited for individuals undergoing testing for high- and moderate-penetrance genes. To address this gap, we evaluated the feasibility of the Consumer Genetic Testing Outcomes Evaluation Paradigm (CGT-OEP), a novel approach for studying cognitive, affective, and behavioral outcomes in individuals pursuing physician-mediated genetic testing. We recruited participants to purchase Color Health's genetic test for cancer and cardiovascular disease risk. Participants completed Baseline (T0),…

See all on PubMed